Professional Expertise Minimally invasive treatment of bladder cancer, prostate cancer, and renal cancer (e.g., diagnosis and minimally invasive treatment of complex cases involving tumors of the kidney, ureter, bladder, prostate, testis, and adrenal gland, as well as complicated urolithiasis). Long-term engagement in clinical urology practice, with a solid theoretical foundation in urology and extensive clinical experience. Proficient in performing complex surgeries, including robot-assisted laparoscopic radical cystectomy, radical prostatectomy, radical nephrectomy and partial nephrectomy, laparoscopic retroperitoneal lymph node dissection, endoscopic inguinal lymph node dissection, and laparoscopic pyeloplasty. Education Peking University Health Science Center, Doctor of Medicine (M.D.) degree from the eight-year clinical medicine program Joint residency training by the Chinese-American Urological Association Clinical visiting scholar at the Li Ka Shing Faculty of Medicine, The University of Hong Kong Peer Reviewer for Academic Journals UROLOGY, International Journal of Urology Editorial Board Member of Academic Publications 1. Guidelines for the Diagnosis and Treatment of Urological Diseases in China (2019 and 2022 editions) 2. Training Curriculum for Urology Specialists in China 3. Atlas of Minimally Invasive Urological Surgery (2nd edition) 4. Hinman's Atlas of Urologic Surgery (3rd edition) 5. Challenging Issues in Laparoscopic Urological Surgery Awards and Honors 2024 Huaxia Medical Science and Technology Award, Science and Technology Award, Third Prize (6/13) 2023 Outstanding Communist Party Member, Peking University Health Science Center 2019 Excellent Paper Award, Annual Meeting of the Urologist Branch of the Chinese Medical Doctor Association 2017 Outstanding Young Physician Award, Peking University Third Hospital 2016 Cheng Yu Tung Scholarship, The University of Hong Kong 2011 1st Place, Laparoscopic Skills Competition, China-Europe Urology Young Physician Training Program (CUEP) Principal Investigator of Major Research Projects 1. Key Research Project of the Beijing Municipal Natural Science Foundation: Clinical application of cell membrane receptor AND logic gates in bladder cancer, Principal Investigator 2. Peking University Medical Youth Development Fund: Study on the effects of PARP inhibitors on DNA damage sensitivity in prostate cancer tumor cells, Principal Investigator 3. Clinical Key Project for Young Investigators, Peking University Third Hospital: Exploratory study on three-dimensional reconstruction of the urethra during laparoscopic radical prostatectomy, Principal Investigator 4. National Key Research and Development Program: Study on the biological effects and immunomodulatory mechanisms of ultrasound cavitation in opening the blood-prostate barrier, Key Member